Tag: CPAP Therapy
ResMed buys HST company
October 4, 2021HME News Staff
SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.
The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.
"Sleep labs and home tests each have critical roles to...
Philips: Don't use bacteria filters with CPAPs
August 12, 2021HME News Staff
CAMBRIDGE, Mass. – Philips does not recommend using bacteria filters with CPAP/BiLevel devices as a means of mitigating chemical emission or particulate matter, it says in a new document related to a recent recall.
“Due to an influx of questions, additional information is being provided about the use of bacteria filters with CPAP/BiLevel devices,” the company states. “According to FDA regulation 868.5260, bacteria filters are medical devices that are intended to remove...
Philips recall: AASM calls for support from CMS, payers
June 24, 2021HME News Staff
DARIEN, Ill. – The American Academy of Sleep Medicine and other professional organizations are making the case to CMS and private payers that the 90-day adherence rule for PAP therapy should be temporarily suspended in the wake of the Philips recall.
“Given that many patients will be affected by the recall, we are requesting support from CMS and private payers to temporarily suspend the 90-day adherence rule to allow patients to have existing equipment repaired or receive new...
Draft assessment questions impact of CPAP therapy
April 19, 2021HME News Staff
WASHINGTON – Published studies mostly do not support that CPAP therapy affects long-term, clinically important outcomes, according to a 155-page draft technology assessment prepared for the Agency for Healthcare Research and Quality at the U.S. Department of Health and Human Services.
Specifically, with low strength of evidence, randomized controlled trials do not demonstrate that CPAP therapy affects all-cause mortality, various cardiovascular outcomes, changes in psychological measures...
OSA should be considered important factor in risk of COVID-19, analysis finds
April 12, 2021HME News Staff
YARMOUTH, Maine – Patients with obstructive sleep apnea (OSA) should be given extra care and monitoring to minimize exposure to COVID-19, according to an analysis published in Sleep Medicine. Physicians can use telemedicine-based practice to provide care and evaluations for OSA patients to minimize their visits to hospitals. Physicians and caregivers should also be engaged in close monitoring of OSA patients with suspected COVID-19 for early diagnosis and treatment to avoid severe...
The CPAP Shop, Sleep Care take diagnosis, treatment fully remote
April 5, 2021HME News Staff
NEW YORK – The CPAP Shop, an online retailer of sleep equipment, and Sleep Care online, a national sleep telemedicine services provider, have partnered to expand access to their solutions. Through the partnership, patients will have access to technology to diagnose sleep disorders, have one-on-one virtual consultations with board-certified sleep physicians and receive prescriptions for sleep therapy through Sleep Care online; and they will have access to customized recommendations...
CPAP therapy increases physical activity, study says
February 18, 2021HME News Staff
DARIEN, Ill. – A new study has found that CPAP therapy leads to increased physical activity in adults with sleep apnea and heart disease. “We were pleased to find that our CPAP users reported that they were better able to maintain their levels of activity over the four years of the study, and that they reported fewer limitations in moderate and vigorous activities, including those that are important for independent aging, like walking up the stairs,” said study co-author Kelly...
CPAP therapy: Don't forget about younger patients, women and mildly diagnosed, study finds
May 21, 2019HME News Staff
DALLAS - Men with sleep apnea are 8.5% more likely to stay adherent on CPAP therapy than women, according to a study presented by ResMed at the American Thoracic Society's ATS 2019 International Conference here. Other findings of the study: people over age 60 were 7.3% more adherent than the entire study cohort (77.7% vs. 70/4%); and people with self-reported severe sleep apnea were 78% adherent at the one-year mark, compared to 70.5% of those with self reported moderate sleep apnea and 65.2% of...
CPAP therapy reduces risk of heart failure for all, study finds
July 17, 2018HME News Staff
YARMOUTH, Maine - Sleep apnea not treated with CPAP therapy was associated with an increased risk of heart failure in patients of all ages, according to a nationwide cohort study recently published in the Journal of the American Heart Association. Using nationwide databases, the study followed the entire Danish population from 2000 until 2012. Patients with sleep apnea receiving and not receiving CPAP therapy were identified and compared with the background population. The primary end point was first-time...
New study links non-adherence to CPAP therapy to hospital readmissions
February 23, 2018HME News Staff
DARIEN, Ill. - Non-adherence to CPAP therapy is significantly associated with increased 30-day hospital readmissions, according to a study of patients with obstructive sleep apnea published in the Feb. 15 issue of Journal of Clinical Sleep Medicine.Non-adherent patients were three times more likely to be readmitted to the hospital within 30 days for any cause, the study shows."Until now no one has investigated the role of CPAP non-adherence in 30-day readmissions as an independent risk factor...